Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
CLDN6
Name:
claudin 6
Location:
16p13.3
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT06515613 | A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors | View | |
| NCT02054351 | Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer OVAR | View | |
| NCT04503278 | A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors | View | |
| NCT05262530 | Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid Tumors | View | |
| NCT05317078 | A Phase 1 Safety Tolerability and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer Epithelial Ovarian Cancer and Other Malignant Solid Tumor Indications | View | |
| NCT05394675 | A Study of DS-9606a in Patients With Advanced Solid Tumors | View | |
| NCT05735366 | A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors | View | |
| NCT06223256 | A Study of NBL-028 in Patients With Advanced Solid Tumors | View | |
| NCT06276491 | Phase 1 Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors | View | |
| NCT03760081 | A Study to Assess the Safety and Efficacy of ASP1650 a Monoclonal Antibody Targeting Claudin 6 CLDN6 in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors | View |